Acadian Asset Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$20.56 - $63.12 $39,598 - $121,569	-1,926 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$28.14 - $73.01 $44,151 - $114,552	1,569 Added 439.5%	1,926 $122,000
Q3 2019 Nov 07, 2019	SELL	$26.26 - $34.86 $24,474 - $32,489	-932 Reduced 72.3%	357 $10,000
Q2 2019 Aug 08, 2019	BUY	$17.43 - $28.82 $22,467 - $37,148	1,289 New	1,289 $34,000
Q2 2018 Jul 24, 2018	SELL	$6.37 - $14.02 $257,679 - $567,137	-40,452 Closed	0 $0
Q1 2018 Apr 12, 2018	SELL	$3.72 - $7.64 $116,108 - $238,459	-31,212 Reduced 43.55%	40,452 $291,000
Q4 2017 Jan 18, 2018	BUY	$3.14 - $4.5 $207,412 - $297,247	66,055 Added 1177.66%	71,664 $264,000
Q3 2017 Oct 13, 2017	BUY	$1.69 - $4.33 $9,479 - $24,286	5,609	5,609 $24,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.